Related Experiment Video
Updated: Apr 28, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Sticky platelet syndrome: history and future perspectives
Peter Kubisz1, Guillermo J Ruiz-Argüelles2, Jan Stasko1
1Department of Haematology and Transfusion Medicine, National Center of Haemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin of the Comenius University in Bratislava, University Hospital in Martin, Martin, Slovakia.
Sticky Platelet Syndrome (SPS) is a platelet disorder causing thrombosis and pregnancy issues. Research is ongoing to clarify its causes, inheritance, and prevalence.
Area of Science:
- Hematology
- Genetics
- Reproductive Medicine
Background:
- Sticky Platelet Syndrome (SPS) is a familial, autosomal dominant qualitative platelet disorder.
- Characterized by hyperaggregable platelets in response to low-dose adenosine diphosphate and/or epinephrine.
- SPS is linked to arterial thrombosis, pregnancy complications, and venous thromboembolism.
Observation:
- SPS is often an underlying cause of unexplained thrombosis, especially arterial events like stroke.
- Despite being recognized for over 30 years, its etiology, inheritance patterns, and epidemiology remain largely unknown.
- Key contributions to understanding SPS were made by Mammen and Bick.
Findings:
- This review summarizes 35 years of research and historical context of SPS.
- It highlights the foundational work of investigators Mammen and Bick.
- The review also outlines current knowledge and future research directions for SPS.
Implications:
- Further research into SPS etiology and epidemiology is crucial for accurate diagnosis and management.
- Understanding SPS can improve outcomes for patients with unexplained thrombosis and recurrent pregnancy loss.
- Clarifying inheritance patterns will aid in genetic counseling for affected families.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Peripheral Artery Disease I: Introduction

